Novartis' Cosentyx® shows almost all psoriasis patients rapidly regain skin clearance following a treatment pause

EAST HANOVER, N.J., March 6, 2017 /PRNewswire/ — Novartis announced today a new analysis (post hoc) of an uncontrolled extension study which shows moderate to severe plaque psoriasis patients treated with Cosentyx® (secukinumab) rapidly regained clear or almost clear skin (Psoriasis Area Sever